Hydrocodone Benzoic Acid Enol Ester Synthesis via In Situ Freebase Generation

Solution Overview

Problem

Existing processes for preparing hydrocodone benzoic acid enol ester are inefficient and expensive, requiring the isolation of pure hydrocodone, which complicates the production of high-quality products.

Innovation Solution

A new process that eliminates the need for isolating pure hydrocodone, allowing for the direct treatment of hydrocodone freebase with a benzoylating reagent to form hydrocodone benzoic acid enol ester, which can then be recrystallized to produce various polymorphic forms, including Forms I to V, and an amorphous form, using specific solvents and conditions to achieve high purity and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If pure hydrocodone is isolated from hydrocodone bitartrate before preparation, then the quality of the final product is improved, but the production cost increases and efficiency decreases

Engineering Contradiction:

Improveproduct qualityVSAvoidproduction efficiency

Core Design Contradiction:

Manufacturing precisionVSProductivity

Solution Approach 1:

The patent applies preliminary action by performing the benzoylation reaction directly on hydrocodone bitartrate without prior isolation of pure hydrocodone. The bitartrate salt is converted to the free base in situ during the benzoylation process, eliminating the need for separate purification steps while maintaining product quality.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent merges multiple steps into one by combining the salt conversion and benzoylation reactions. The process directly treats hydrocodone bitartrate with benzoylating reagent, merging the liberation of free base and the esterification step into a single operational sequence, thereby improving efficiency without sacrificing quality.

Inventive Principle:

Principle #5Merging (Combining)

2Manufacturing precision

If pure hydrocodone is isolated from hydrocodone bitartrate before preparation, then the quality of the final product is improved, but the production cost increases

Engineering Contradiction:

Improveproduct qualityVSAvoidproduction cost

Core Design Contradiction:

Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent applies preliminary action by performing the benzoylation reaction directly on hydrocodone bitartrate without prior isolation of pure hydrocodone. The bitartrate salt is converted to the free base in situ during the benzoylation process, eliminating the need for separate purification steps while maintaining product quality.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent merges multiple steps into one by combining the salt conversion and benzoylation reactions. The process directly treats hydrocodone bitartrate with benzoylating reagent, merging the liberation of free base and the esterification step into a single operational sequence, thereby improving efficiency without sacrificing quality.

Inventive Principle:

Principle #5Merging (Combining)

3Manufacturing precision

If recrystallization is performed to obtain high purity hydrocodone benzoic acid enol ester, then the purity level is improved, but the production time increases

Engineering Contradiction:

Improvepurity levelVSAvoidproduction time

Core Design Contradiction:

Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent applies parameter changes by optimizing recrystallization conditions including solvent selection (ethyl acetate, isopropyl alcohol, or their mixtures), temperature profiles, and pH control during the process. These parameter optimizations enable achieving high purity levels while minimizing the time required for crystallization and filtration steps.

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process results in a highly pure hydrocodone benzoic acid enol ester with impurities less than 0.1%, enabling the production of stable polymorphic forms with improved bioavailability and reducing production costs by using crude hydrocodone as a starting material.

Implementation Method 1

treatment of hydrocodone freebase with a benzoylating reagent to form hydrocodone benzoic acid enol ester

Methodology Applied

Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 2

recrystallized to produce various polymorphic forms, including Forms I to V, and an amorphous form

Methodology Applied

Scientific EffectRecrystallization: Crystallisation

Data Source

PatentUS10870654B2Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same

Publication Date: 2020.12.22 ZEVRA THERAPEUTICS INC

AI summary

Compositions comprising hydrocodone benzoic acid enol ester to form novel prodrugs including hydrocodone benzoic acid enol ester salts, and various polymorphs. Also provided are processes for the preparation of hydrocodone benzoic acid enol ester salts, and various polymorphs.